NASDAQ:MRNS

Marinus Pharmaceuticals Price Target, Predictions & Analyst Ratings

$11.13

+0.02 (+0.18 %)

(As of 10/22/2021 04:00 PM ET)

Add

Compare

Today's Range

$11.03

▼

$11.24

50-Day Range

$11.03

▼

$13.12

52-Week Range

$10.71

▼

$20.04

Volume154,159 shs

Average Volume254,793 shs

Market Capitalization$408.83 million

P/E RatioN/A

Dividend YieldN/A

Beta1.21

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 7 Analyst Ratings

Analyst Price Target Consensus

$33.33

High PT	$40.00
Average PT	$33.33
Low PT	$23.00

Type	Current 10/23/20 to 10/23/21	1 Month Ago 9/23/20 to 9/23/21	3 Months Ago 7/25/20 to 7/25/21	1 Year Ago 10/24/19 to 10/23/20
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	9 Buy rating(s)	9 Buy rating(s)	10 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$33.33	$31.00	$29.11	$27.78
Price Target Upside	199.49% Upside	170.25% Upside	161.03% Upside	215.54% Upside

Get Marinus Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MRNS and its competitors with MarketBeat's FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Marinus Pharmaceuticals (NASDAQ:MRNS) vs. Its Competitors

Type	Marinus Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.73	2.56
Consensus Rating	Buy	Buy	Buy
Price Target Upside		146.59% Upside	6.73% Upside
News Sentiment Rating	Neutral News	Neutral News	Neutral News
MarketBeat Community Rating	Outperform Votes 398 72.10% Underperform Votes 154 27.90%	Avg. Outperform Votes 179 67.55% Avg. Underperform Votes 86 32.45%	Avg. Outperform Votes 831 69.48% Avg. Underperform Votes 365 30.52%

Marinus Pharmaceuticals (NASDAQ:MRNS) Analyst Ratings History

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/18/2021	SVB Leerink	M. Goodman	Reiterated Rating	Outperform
10/5/2021	JMP Securities	Jason Butler	Reiterated Rating	Buy	$23.00	+101.58%
8/19/2021	Robert W. Baird		Reiterated Rating	Buy	$32.00	+178.75%
8/18/2021	Truist Securities		Boost Price Target	Buy	$35.00 ➝ $40.00	+248.43%
8/17/2021	Cantor Fitzgerald	A. Young	Reiterated Rating	Overweight
3/10/2021	HC Wainwright		Boost Price Target	Buy	$35.00 ➝ $38.00	+104.08%
9/25/2020	LADENBURG THALM/SH SH		Reiterated Rating	Buy	$20.00	+86.92%
9/23/2020	Oppenheimer	Jay Olson	Boost Price Target	Outperform	$7.00 ➝ $28.00	+791.72%
9/15/2020	Jefferies Financial Group		Boost Price Target	Buy	$16.00 ➝ $24.00	+184.36%
7/1/2020	Cowen		Initiated Coverage	Outperform

4/9/2020	Craig Hallum		Initiated Coverage	Buy	$18.00	+172.73%
7/23/2019	Mizuho		Lower Price Target	Neutral	$20.00 ➝ $6.80	+36.00%

(Data available from 10/23/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Marinus Pharmaceuticals (NASDAQ:MRNS) Analyst Ratings Frequently Asked Questions

What is Marinus Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 7 analysts in the last year, the consensus rating for Marinus Pharmaceuticals stock is Buy based on the current 7 buy ratings for MRNS. The average twelve-month price target for Marinus Pharmaceuticals is $33.33 with a high price target of $40.00 and a low price target of $23.00. Learn more on MRNS's analyst rating history
Do Wall Street analysts like Marinus Pharmaceuticals more than its competitors?: Analysts like Marinus Pharmaceuticals stock more than the stock of other Medical companies. The consensus rating score for Marinus Pharmaceuticals is 3.00 while the average consensus rating score for medical companies is 2.73. Learn more on how MRNS compares to other companies
Do MarketBeat users like Marinus Pharmaceuticals more than its competitors?: MarketBeat users like Marinus Pharmaceuticals stock more than the stock of other Medical companies. 72.10% of MarketBeat users gave Marinus Pharmaceuticals an outperform vote while medical companies recieve an average of 67.55% outperform votes by MarketBeat users.

Does Marinus Pharmaceuticals's stock price have much upside?: According to analysts, Marinus Pharmaceuticals's stock has a predicted upside of 156.34% based on their 12-month price targets.
What analysts cover Marinus Pharmaceuticals?: Marinus Pharmaceuticals has been rated by Cantor Fitzgerald, JMP Securities, Robert W. Baird, SVB Leerink, Truist, and Truist Securities in the past 90 days.

This page was last updated on 10/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Marinus Pharmaceuticals Price Target, Predictions & Analyst Ratings

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target and Consensus Rating